Last updated on August 2016

Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer


Brief description of study

This study evaluates the efficacy and safety of DWJ1319 in the prevention of gallstone formation after gastrectomy in patient with gastric cancer. Two-thirds of the participants will receive DWJ1319, while the other will receive a placebo.

Clinical Study Identifier: NCT02490111

Contact Investigators or Research Sites near you

Start Over

Do Joong Park, M.D., Ph.D.

National Cancer Center
Goyang-si, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

Seoul Natioanl University Bundang Hospital
Seongnam-si, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

Chonnam National University Hwasun Hospital
Hwasun-gun, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

Pusan National University Yangsan Hospital
Yangsan, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

Kyungpook national university medical center
Daegu, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

Chungnam national university hospital
Daejeon, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

Samsung Medical Center
Seoul, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

Asan Medical Center
Seoul, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

Severance Hospital
Seoul, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

SMG-SNU Boramae Medical Center
Seoul, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, Korea, Republic of
  Connect »

Do Joong Park, M.D., Ph.D.

Ajou University Hospital
Suwon, Korea, Republic of
  Connect »